iSonea expands board expertise with new director appointments – Proactive Investors USA & Canada


Proactive Investors Australia

iSonea expands board expertise with new director appointments
Proactive Investors USA & Canada
iSonea recently reached an important milestone with the start of its first large US post-market study of its WheezoMeter™ monitoring device in paediatric patients with a range of asthma symptom severity. The study will include patients who are too
iSonea Announces Changes to Board of DirectorsMarketWatch (press release)

all 10 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.